Pretest probability estimates how likely a condition is before testing, based on the patient’s symptoms and history. It influences how much confidence clinicians place in a test result because selecting a test without considering the initial likelihood can increase false-positive findings. Using this estimate helps clinicians choose investigations more selectively and avoid unnecessary follow-up procedures.
Different tests examine different evidence of disease, including biological signals, functional responses, anatomical features, or disease-associated markers. This allows clinicians to investigate a suspected condition from the aspect most relevant to the clinical question. The choice of measurement can therefore refine the differential diagnosis when routine evaluation has not provided enough information.
Reference ranges provide a comparison framework for interpreting a measured result, but they do not replace clinical judgment. Clinicians consider the range alongside symptoms, medical history, pretest probability, and other findings. This combined interpretation helps distinguish a potentially meaningful abnormality from an isolated result that may not adequately support a suspected diagnosis.
Selection should begin with the patient’s symptoms, history, and the condition under consideration. Clinicians then identify whether the needed information concerns a biological marker, functional response, anatomical feature, patient sample, imaging finding, or physiological assessment. Matching the test to the clinical question improves the usefulness of the result and limits investigations that are unlikely to clarify the case.
They are useful when routine evaluation leaves several possible explanations or does not provide enough information to distinguish among them. A targeted result can add evidence about a suspected condition and narrow the differential diagnosis. This role is especially relevant when the clinician must decide whether the available findings support further evaluation, a treatment decision, or closer monitoring.
Results may help clinicians identify disease earlier, select a management approach, or assess whether findings change over time. For monitoring, test results are interpreted in relation to the patient’s clinical course rather than viewed in isolation. Repeated or complementary assessments can therefore provide information about progression, while careful selection helps reduce unnecessary procedures and misleading findings.